Explain this page
Arphra AIPlain-English read on GE HealthCare Technologies Inc.’s valuation06-15today
- GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia8d
- GE HealthCare Gains FDA Clearance for AI Radiation Planning Software18d
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities19d
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities19d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$87.63
+37.52% vs spot
Recommendation
Strong Buy
20 of 21 methods
Method spread
10bull10bear
±5% threshold
Analyst PT consensus: $84.00 (+31.83%)
Candlestick · 1Y
Open in chart workstation →GEHC
61.59-14.43%H 89.77L 58.75MA50 65.40MA200 74.64Avg vol 3.9M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.08% | +5.46% | -0.79% | -11.07% | -23.52% | -22.31% | -10.46% | -20.17% | +6.20% | +6.20% | +6.20% |
Insider · 30d
History →Bought
$5.78M
7 txns
Sold
$573.29K
3 txns
Net flow
+$5.21M
Aftermarket
LiveLast trade
$63.86
15 sh
Bid
$62.62
10 sh
Ask
$64.00
10 sh
Spread
$1.380
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $5.13B | $389M | $0.85 |
| Q4 Dec 2025 | $4.67B | $184M | $0.38 |
| Q3 Sep 2025 | $5.14B | $446M | $0.98 |
| Q2 Jun 2025 | $5.01B | $486M | $1.06 |
| Q1 Mar 2025 | $4.78B | $564M | $1.23 |
| Q4 Dec 2024 | $5.32B | $720M | $1.57 |
Sector & industry today
LiveSectors
- Technology+2.51%
- Industrials+1.00%
- Basic Materials+0.65%
- Energy+0.59%
- Financial Services+0.23%
- Healthcare-0.18%
- Communication Services-0.18%
- Consumer Defensive-0.30%
- Consumer Cyclical-0.85%
- Real Estate-0.99%
- Utilities-1.03%
Top industries (issuer's industry highlighted)
- Medical - Healthcare Information Services+0.26%
- Software - Services+9.60%
- Broadcasting+8.34%
- Medical - Equipment & Services+5.08%
- Computer Hardware+4.56%
- Financial - Mortgages+4.08%
- Staffing & Employment Services-3.62%
- Internet Content & Information+3.58%
- Coal-3.56%
- Oil & Gas Energy-3.54%
- Biotechnology+3.28%
- Electrical Equipment & Parts+3.27%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$84.00
+31.83% upside
Low
$65.00
Median
$85.00
High
$105.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- GEHC Expands Carilion Tie to Enhance Patient Care Across Virginiazacks.com·Jun 15, 2026
- GE HealthCare Gains FDA Clearance for AI Radiation Planning Softwarezacks.com·Jun 05, 2026
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesbusinesswire.com·Jun 04, 2026
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesbusinesswire.com·Jun 04, 2026
- GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
- GE HealthCare Technologies Inc. (GEHC) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Toolszacks.com·May 12, 2026
- GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impactbusinesswire.com·May 11, 2026
Recent analyst activity
DB- Jun 23, 2026GradeOutperformGE HealthCare initiated with an Outperform at RBC CapitalRBC Capital
- Jun 23, 2026PT$80.00GE HealthCare initiated with an Outperform at RBC CapitalRBC Capital
- Jun 08, 2026GradeNeutral → NeutralGoldman Sachs Reiterates Neutral Rating on GE HealthCare (GEHC) Post Management MeetGoldman Sachs
Financial scores
DBJun 23, 2026Altman Z
1.65
Distress
≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress
Piotroski F
6/9
Average
≥ 7 strong · 4–6 average · < 4 weak
Peers
Total assets
$36.91B
Total debt
$10B
Cash & equiv
$4.51B
Operating CF
$1.99B
Free cash flow
$1.51B
Buybacks
-$200M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Hochman Rodney F director | Buy | 1,618 | $100.36K | May 12, 2026 |
Yang Watkin Phoebe L. director | Buy | 1,000 | $63.01K | May 08, 2026 |
Stromberg William J director | Buy | 1,000 | $61.69K | May 06, 2026 |
CULP H LAWRENCE JR director | Buy | 80,805 | $5M | May 06, 2026 |
SACCARO JAMES officer: Chief Financial Officer | Buy | 3,310 | $200.59K | May 01, 2026 |
Jimenez Frank R officer: GC & Corporate Secretary | Buy | 1,750 | $105.79K | Apr 30, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $20.63B | $2.76B | $2.08B | $4.55 | +10.10% |
| FY 2024 | $19.67B | $2.63B | $1.99B | $4.34 | +10.13% |
| FY 2023 | $19.55B | $2.44B | $1.57B | $3.02 | +8.02% |
| FY 2022 | $18.34B | $2.52B | $1.92B | $4.22 | +10.45% |
| FY 2021 | $17.59B | $2.8B | $2.25B | $4.90 | +12.78% |